Welcome to the investors section of Adocia

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.

Adocia Corporate Presentation October 2019 de adocia

Latest Press Releases

2019/11/07Number of shares and voting rights of ADOCIA as of October 31st, 2019
2019/10/22Adocia Announces Third Quarter 2019 Financial Results

All Press releases

Next events

November 14, 2019 Agora Biotech Event will host Adocia, Paris, France - Agora Biotech's mission is to introduce investors to highly innovative companies in the field of Life Sciences, offering breakthrough innovations such as Adocia. Link to the registrations soon available on Adocia Website.

All events

ADOCIA uses cookies for the effective operation of the Site and to monitor and analyze the traffic on the Site.
The information collected through cookies is solely and strictly for ADOCIA, in compliance with the regulation applicable to the protection of personal data. They are never transmitted to third-parties.

Financial

Welcome to the investors section of Adocia

A video Interview with Gérard Soula, Adocia CEO: “China, this is the place to be

November 14th 2019 – Biotech Agora will host Adocia, Paris, France